Core Laboratories vs Recon Technology
CLB and RCON side by side, both in oil and gas field services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLB and RCON compare
Recon Technology grew revenue faster over the last twelve months (65.8% versus −0.15% for Core Laboratories).
Core Laboratories keeps more of each dollar of sales as profit, with a net margin of 3.0% compared with −27.0% at Recon Technology.
Core Laboratories pays a dividend yielding 0.33%; Recon Technology does not pay one.
Core Laboratories scores higher on the StockData Score (11 against 5 for Recon Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLB | RCON |
|---|---|---|
| Size and price | ||
| Market cap | $413M | – |
| Share price | $9.01 | $0.850 |
| Change, 1 year | −44.2% | −99.7% |
| Change, 5 years | −63.0% | −100.0% |
| Beta (5Y) | 1.13 | 0.71 |
| Employees | 3,300 | 194 |
| StockData Score | ||
| Total score | 11 (better) | 5 |
| Valuation score | 1 (better) | 0 |
| Growth score | 2 | 3 (better) |
| Performance score | 2 (better) | 1 |
| Health score | 2 (better) | 1 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 26.5× | – |
| P/S | 0.8× | – |
| P/B | 1.5× | – |
| EV/EBITDA | 9.5× | – |
| P/FCF | 39.8× | – |
| PEG | 1.83 | – |
| FCF yield | 2.5% | – |
| Fair value | $8.21 | – |
| Margin of safety | −9.7% | – |
| Growth | ||
| Revenue growth (TTM) | −0.15% | 65.8% (better) |
| Revenue growth, 5Y average | – | 18.0% |
| Net income growth (TTM) | −51.6% | – |
| EPS growth (TTM) | −50.0% | – |
| Profitability | ||
| Gross margin | 19.1% | 33.2% (better) |
| Operating margin | 7.5% (better) | −37.5% |
| Net margin | 3.0% (better) | −27.0% |
| FCF margin | 2.0% | – |
| Return on equity | 5.7% (better) | −5.7% |
| Return on invested capital | 6.0% (better) | −7.3% |
| Financial health | ||
| Debt / equity | 0.40 | – |
| Net debt / EBITDA | 1.69 | – |
| Interest coverage | 3.5× (better) | −39.6× |
| Current ratio | 2.19 | 2.73 (better) |
| Altman Z-score | 2.56 | – |
| Piotroski F-score | 7 (better) | 4 |
| Dividends and buybacks | ||
| Dividend yield | 0.33% | – |
| Payout ratio | 11.9% | – |
| Years of dividend growth | 0 | – |
| Buyback yield | 2.5% | – |
| Shareholder yield | 2.9% | – |
| Ownership | ||
| Held by institutions | 115% | – |
| Held by insiders | 1.5% | 56.5% |
| Insider net buying, 12 months | $53.9K | – |
| Short interest, % of float | 11.0% | – |
Go deeper
- CLB stock overview
- CLB income statement
- CLB valuation and score
- RCON stock overview
- RCON income statement
- RCON valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.